Metabolic effects of oestrogens: Impact of the route of administration

Annales d'Endocrinologie

Volumn 64, Issue 2, 2003, Pages 170-177

  Ho, K K Y ^a   O'Sullivan, A J ^a   Wolthers, T ^a   Leung, K C ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Body composition; Growth hormone; Insulin like growth factor 1; Menopause; Oestrogen; Sex steroids

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; GROWTH HORMONE; SOMATOMEDIN C;

ADIPOSE TISSUE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG FORMULATION; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; LEAN BODY WEIGHT; LIPID OXIDATION; LIVER METABOLISM; METABOLISM; OPEN STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; BODY COMPOSITION; BONE AND BONES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; POSTMENOPAUSE;

EID: 0038665438     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Baruch Y, Amit T, P. H, Enat R, Youdim MBH, Hochberg Z. Decreased serum growth hormone-binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 1991; 73: 777-780.
2. Baumann G, Amburn KD, Buchanan TA. The effect of circulating growth hormone-binding protein on metabolic clearance, distribution and degradation of human growth hormone. J Clin Endocrinol Metab 1987; 64: 657-660.
3. Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC. A specific growth hormone-binding protein in human plasma: initial chatracterisation. J Clin Endocrinol Metab 1986; 62: 134-141.
4. Baxter RC. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol Metab 1993; 4: 91-95.
5. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997; 82: 550-555.
6. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P et al. Biological effects of transdermal estradiol. N Engl J Med 1986; 314: 1615-20.
7. Clemmons DR, Underwood LE, Ridgway EG, Kliman B, Kjellberg RN, Van Wyk JJ. Estradiol treatment of acromegaly: reduction of immunoreactive somatomedin C and improvement of metabolic status. Am J Med 1980; 69: 571-75.
8. Copeland KC. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin C and growth in patients with Turners syndrome. J Clin Endocrinol Metab 1988; 66: 1278-1282.
9. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: further Evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci 1984; 81: 935-939.
10. Dawson-Hughes B, Stern D, Goldman J, Reichlin S. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab 1986; 63: 424-432.
11. de Lignieres B, Basdevant A, Thomas G. Biological effects of 17β estradiol in postmenopausal women: oral versus percutaneous adminstration. J Clin Endocrinol Metab 1986; 62: 536-41.
12. Duursma S, Bijlsma J, Van Paassen H, van Buul-Offers S, Skottner-Lundin A. Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women; a pilot study. Acta Endocrinol 1984; 106: 527-31.
13. Faria ACS, Beckenstein LW, Booth RA, Vaccaro VA, Asplin CM, Veldhuis JD et al. Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol 1992; 36: 591-596.
14. Goebelsmann U, Maschak CA, Mishell DR. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol. 1985; 151: 868-877.
15. Gotherstrom G, Svensson J, Koranyi J, Alpsten M, Bosaes I, Bengtsson B-A et al. A prospective study of 5 years of GH replacement therapy in GH- deficient adults: sustained effects on body composition, bone mass and metabolic indices. J Clin Endocrinol Metab 2001; 86: 4657-4665.
16. Herington AC, Ymer S, Stevenson J. Identification and characterisation of specific binding proteins for growth hormone in normal human sera. J Clin Invest 1986; 77: 1817-1823.
17. Ho KKY, Jenkins AB, Furler SM, Borkman M, Chisholm DJ. Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. Clin Endocrinol 1992; 36: 271-279.
18. Ho KKY, Weissberger AJ. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 1992; 7: 821-827.
19. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E et al. Effects of sex and age on the 24 hour secretory profile of GH secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64: 51-58.
20. Ho KY, Valiontis E, Waters MJ, Rajkovic IA. Regulation of growth hormone binding protein in man: comparison of gel chromatography and immunoprecipitation methods. J Clin Endocrinol Metab 1993; 76: 302-308.
21. Jorgensen JOL, Theusen L, Ingemann-Hansen T, Pedersen SA, Jorgensen J, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; 1: 1221-1225.
22. Kam GYW, Leung KC, Baxter RC, Ho KKY. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein 3 and the acid-labile subunit of the IGF ternary complex. J Clin Endocrinol Metab 2000; 85: 1918-1922.
23. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY. Effects of different oestrogen formulations on insulin-like growth factor-1, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol 1993; 39: 561-567.
24. Leung DW, Spencer SA, Cachaines G, Hammojnd RG, Collins C, Henzel WJ et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987; 330: 537-543.
25. Leung KC, N. D, Ballesteros M, Sjogren K, Watts CKW, Low TH, et al. Estrogen inhibits growth hormone (GH) signaling by suppressing GH-induced JAK2 phosphorylation: an effect mediated by SOC2. Proc Natl Acad Sci 2003; in press.
26. Lim L, Spencer SA, McKay P, Waters MJ. Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Endocrinology 1990; 127: 1287-1291.
27. Link K, Blizzard R, Evans W, Kaiser D, Parker M, Rogol A. The effect of androgens on the pulsatile release and the 24-hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab 1986; 62: 159-164.
28. Liu L, Merriam GR, Sherins RJ. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypgonadotropic hypogonadism. J Clin Endocrinol Metab 1987; 64: 58.
29. Mandel FP, Geola FL, Lu J, Eggena P, Sambhi MP, Hershman JM et al. Biological effects of various doses of ethinyl estradiol. American Journal of Obstetrics and Gynecology 1982; 59: 673-679.
30. Maschak CA, Lobo R, Dozono TR, Eggena P, Nakamura RM, Brenner PF et al. Comparison of pharmacokinetic properties of various estrogen formulations. American Journal of Obstetrics and Gynecology 1982; 144: 511-518.
31. Mauras N, Rogol AD, Veldhuis JD. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicular-stimulating hormone and luteinising hormone in prepubertal girls with Turner's syndrome. J Clin Endocrinol Metab 1989; 69: 1053-1058.
32. Moller N, Jorgensen JOL, Alberti KGMM, Flyvbjerg A, Schmitz O. Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab 1990; 70: 1179-1186.
33. Murphy LJ, Freisen HG. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor-1 expression in the ovariectomised hypophysectomised rat. Endocrinology 1988; 122: 325-332.
34. O'Sullivan AJ, Crampton L, Freund J, Ho KKY. Route of estrogen replacement confers divergent effects on energy metabolism and body composition in postmenopausal women. J Clin Invest 1998; 102: 1035-1040.
35. O'Sullivan AJ, Ho KKY. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 1995; 80: 1783-1788.
36. O'Sullivan AJ, Hoffman DM, Ho KKY. Estrogen, lipid oxidation and body fat. N Engl J Med 1995; 333: 660-670.
37. O'Sullivan AJ, MArtin A, Brown MA. Efficient fat storage in premenopausal women and in early pregnancy: a role for estrogen. J Clin Endocrinol Metab 2001; 86: 4951-4956.
38. Ockner RK, Lysenko N, Manning JA, Monroe SE, Burnett DA. Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver. J Clin Invest 1980; 65: 1013-1023.
39. Rajkovic IA, Valiontis E, Ho KKY. Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunctional assay: comparison with immunoprecipitation and chromatography methods. J Clin Endocrinol Metab 1994; 78: 772-777.
40. Rizza R, Mandarino L, Gerich J. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981; 240: E630-E639.
41. Ross JL, Cassorla FG, Skerda MC, Valk IM, Loriaux DL, Cutler GB. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med 1983; 309: 1104-06.
42. Ross JL, Meyerson Long L, Loriaux DL, Cutler GB. Growth hormone secretory dynamics in Turner syndrome. J Pediatr 1985; 106: 202-206.
43. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New Engl J Med 1989; 321: 1797-803.
44. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204.
45. Weinstein I, Soler-Argilaga C, Werner HV, Heimberg M. Effects of ethynyloestradiol on the metabolism of [1-14C] oleate by perfused livers and hepatocytes from female rats. Biochem J 1979; 180: 265-271.
46. Weissberger AJ, Ho KKY. Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 1993; 76: 1407-1412.
47. Weissberger AJ, Ho KKY, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor 1 and GH binding protein in post-menopausal women. J Clin Endocrinol Metab 1991; 72: 374-381.
48. Wennick JMB, Delemare-van-de Waal HA, Schoemaker R, Blaau G, van den Braken C, Schoemaker J. Growth hormone secretion patterns in relation to LH and estradiol secretion throughout normal female puberty. J Clin Endocrinol Metab 1990; 124: 129-135.
49. Wiedemann E, Schwartz E, Frantz A. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man. J Clin Endocrinol Metab 1976; 42: 942-52.
50. Wolthers T, Hoffman DM, Nugent AG, Duncan M, M., Ho KKY. Oral estrogen therapy impairs the metabolic effects of growth hormone (GH) in GH deficient women. Am J Physiol 2001; 281: E1191-E1196.